Sydnexis Inc., is a privately held clinical stage biopharmaceutical company based in San Diego that is developing a proprietary formulation for decreasing myopic progression in children. Sydnexis recently initiated a Phase 3 study testing its patented eyedrop formulation, SYD-101.ydnexis was founded in San Diego in 2014 with the goal of developing a proprietary, stable, topical eyedrop to treat the progression of myopia in chi...
Sydnexis Inc., is a privately held clinical stage biopharmaceutical company based in San Diego that is developing a proprietary formulation for decreasing myopic progression in children. Sydnexis recently initiated a Phase 3 study testing its patented eyedrop formulation, SYD-101.ydnexis was founded in San Diego in 2014 with the goal of developing a proprietary, stable, topical eyedrop to treat the progression of myopia in children.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.